


Pharmasaga
Pharmaceutical Manufacturing • No.99, Lane 130, Taiwan, Province of China • 1-10 Employees
Company overview
| Headquarters | No.99, Lane 130, Sec. 1, Academia Rd., Rm. 443, Building A,, Taipei City, TW |
| Phone number | +886226538670 |
| Website | |
| NAICS | 3254 |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contact at Pharmasaga
Mau-Sheng Hou
Chief Technology Officer
About Pharmasaga
Pharmasaga is an Academia Sinica-derived biotech company, and was founded in Jan-2021. The core technology of Pharmasaga is the inhibitor of PX protein, which plays a critical role in diabetes development. Dr. Yang in Academia Sinica had researched the mechanism of diabetes for more than 20 years, and the technology of diabetes treatment was transferred to Pharmasaga for commercialization.
Pharmasaga revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Pharmasaga has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Pharmasaga has never raised funding before.
Pharmasaga Tech Stack
Discover the technologies and tools that power Pharmasaga's digital infrastructure, from frameworks to analytics platforms.
CDN
SSL/TLS certificate authorities
Web servers
Frequently asked questions
4.8
40,000 users



